My research interest lies in developing new therapies for patients with squamous cell carcinomas of the lung. Treatment options for patients with this type of lung cancer have lagged behind those for patients with lung adenocarcinomas. We are, however, beginning to unravel the molecular complexity of this disease, which we hope will herald in a new era of personalized medicine for our patients.
Ultimately, the goal of our care is to maintain the dignity of our patients and to address their unique and disparate needs. The research I perform is meant to foster this, by providing the hope of better survival and improved quality of life.